Nobivac LeuFel

RSS

Feline leukaemia vaccine (inactivated)

Authorised
This medicine is authorised for use in the European Union.

Overview

Nobivac LeuFel is a veterinary vaccine used in cats from eight weeks of age to protect them against feline leukaemia. Feline leukaemia is an infectious disease of cats which affects the immune system and is caused by the feline leukaemia virus (FeLV). Signs of the disease can include loss of appetite, weight loss, poor fur condition, fever, pale gums and diarrhoea; cats persistently infected with the virus may spread it to other cats. The vaccine is used to prevent the disease signs and persistent viraemia (the presence of FeLV in the blood).

The medicine contains a protein from the outer layer of FeLV.

This medicine is the same as Leucogen, which is already authorised in the European Union (EU). The company that makes Leucogen has agreed that its scientific data can be used for Nobivac LeuFel (‘informed consent’).

This EPAR was last updated on 07/10/2021

Authorisation details

Product details
Name
Nobivac LeuFel
Agency product number
EMEA/V/C/004778
Active substance
purified Rp-45 FeLV-envelope antigen
International non-proprietary name (INN) or common name
Feline leukaemia vaccine (inactivated)
Species
Cats
Anatomical therapeutic chemical veterinary (ATCvet) codes
QI06AA01
Publication details
Marketing-authorisation holder
Virbac S.A.
Revision
3
Date of issue of marketing authorisation valid throughout the European Union
06/11/2017
Contact address

1ère Avenue 2065 M - L.I.D.
06516 Carros Cedex
France

Product information

07/10/2021 Nobivac LeuFel - EMEA/V/C/004778 - IG-1409

Other EU languages available icon This medicine’s product information is available in all official EU languages.
Select ‘available languages’ to access the language you need.

 

Product information documents contain:

You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.

Pharmacotherapeutic group

Inactivated viral vaccines

Therapeutic indication

Active immunisation of cats from eight weeks of age against feline leukaemia for the prevention of persistent viraemia and clinical signs of the related disease.

Assessment history

How useful was this page?

Add your rating